Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Genetic Mechanisms of Infantile Epilepsies and the Impact of Genetic Diagnosis: Gene-Shortening Time of Evaluation in Pediatric Epilepsy Services (Gene-STEPS)

NCT06701084 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT06701084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06701084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Genetic Mechanisms of Infantile Epilepsies and the Impact of Genetic Diagnosis: Gene-Shortening Time of Evaluation in Pediatric Epilepsy Services (Gene-STEPS)
Lead sponsor
Boston Children's Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
September 2, 2021
Completion date
November 30, 2029
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infantile epilepsy, neonatal epilepsy